89bio, Inc. (ETNB)
NASDAQ: ETNB · Real-Time Price · USD
10.25
+0.29 (2.91%)
At close: Jun 6, 2025, 4:00 PM
10.20
-0.05 (-0.49%)
After-hours: Jun 6, 2025, 5:05 PM EDT
89bio Employees
89bio had 93 employees as of December 31, 2024. The number of employees increased by 23 or 32.86% compared to the previous year.
Employees
93
Change (1Y)
23
Growth (1Y)
32.86%
Revenue / Employee
n/a
Profits / Employee
-$4,157,774
Market Cap
1.50B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ETNB News
- 2 hours ago - 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 days ago - 89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - 89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - 89bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - 89bio Reports First Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 7 weeks ago - 89bio: A Buy With Strong Market Opportunity In MASH And SHTG - Seeking Alpha
- 3 months ago - 89bio to Participate in the Leerink Partners Global Healthcare Conference - GlobeNewsWire
- 3 months ago - 89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates - GlobeNewsWire